Raptor Pharmaceuticals (RPTP) Stock Bought Out: Here’s What You Need To Know

Raptor Pharmaceuticals (NASDAQ:RPTP) On Monday, Horizon Pharma bought out Raptor Pharmaceuticals for $800 million ┬áin an all cash deal. Taking into account the amount of cash in the buyout, it translates to $9 per share. Although the stock traded higher by 20.3% to $8.96. Before the news of the announcement Raptor’s stock traded at $7.45 … Read more

Biotech Stock News (RPTP) (AERI) (CANF)

Raptor Pharmaceuticals (NASDAQ:RPTP) On Monday September 14, 2015 shares of Raptor Pharmaceuticals ended the day down 38% after the company announced that it had failed a phase 2b liver study in children with NASH — non-alcoholic steatohepatitis. The phase 2b trial enrolled up to 169 children with NASH between the ages of eight and seventeen. … Read more